WebInvestor Relations. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to ... WebMar 30, 2024 · Charles River Laboratories Annual Report 2024 3 Revenue by Geography (excluding Japan) 30% Europe 5% Asia-Pacific 65% North America Revenue by Client Segment ~10% Academic/Gov. ~30% Globals ~20% Other ~40% Biotech . Free cash flow increased by 40.0%, to $532.0 million, due to the strong ...
Charles River and Ziphius Vaccines Collaborate to Manufacture …
WebApr 11, 2024 · WILMINGTON, Mass., April 11, 2024--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 11 th, before the market opens.A conference call has been scheduled to discuss this information on Thursday, May 11 th, at 8:30 a.m. ET.. Investors will have … WebDec 26, 2009 · Investor Relations. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they … nac healthwise price
June Investor Conference Presentation - Charles River …
WebMar 15, 2024 · Investor Relations. Investor Relations Home; Corporate Governance; Corporate Citizenship ; Investor Day 2024; Annual Meeting 2024; Stock Information; … Presentations - Investor Overview Charles River Laboratories International, Inc. Investor Relations Home - Investor Overview Charles River Laboratories … Corporate Governance - Investor Overview Charles River Laboratories … We would like to show you a description here but the site won’t allow us. Annual Meeting 2024 - Investor Overview Charles River Laboratories International, … Stock Information - Investor Overview Charles River Laboratories International, … News Releases Charles River Laboratories International, Inc. Financial Information - Investor Overview Charles River Laboratories International, … SEC Filings - Investor Overview Charles River Laboratories International, Inc. Analyst Information - Investor Overview Charles River Laboratories International, … WebCharles River Investors : Todd Spencer Corporate Vice President, Investor Relations +1- 781-222-6455 [email protected] Charles River Media: Amy Cianciaruso Corporate Vice President & Chief Communications Officer +1-781-222-6168 [email protected] Source: Charles River Laboratories International, Inc. WebApr 11, 2024 · WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on … nac heart